resveratrol has been researched along with Clasp-Knife Spasticity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altucci, L; Bucci, T; Carafa, V; Carrizzo, A; Ciccarelli, M; Damato, A; Di Nonno, F; Di Pietro, P; Frati, G; Giudice, V; Giugliano, G; Iside, C; Izzo, R; Nebbioso, A; Puca, AA; Sciarretta, S; Scioli, M; Selleri, C; Serio, B; Storto, M; Trimarco, B; Trimarco, V; Valenti, V; Vecchione, C; Venturini, E | 1 |
| Jankauskas, SS; Mone, P; Santulli, G | 1 |
2 other study(ies) available for resveratrol and Clasp-Knife Spasticity
| Article | Year |
|---|---|
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency.
Topics: Animals; Genotype; Homocystinuria; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Muscle Spasticity; Psychotic Disorders; Resveratrol; Sirtuin 1; Thrombosis | 2022 |
From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency.
Topics: Homocystinuria; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Muscle Spasticity; Psychotic Disorders; Resveratrol; Sirtuin 1; Thrombosis | 2022 |